Advertisement
Home Tags Cancer: Brain

Tag: Cancer: Brain

Occult Brain Mets Detected in Patients With Advanced Renal Cancer

Asymptomatic brain metastases incidentally diagnosed in about 4 percent of patients with mRCC during clinical trial screening

Timing of Chemotherapy for Glioblastoma May Matter

Treatment in the morning may be more effective, with greater impact seen in MGMT-methylated patients

B 1/13 -- New Insights Into How COVID-19 Damages the Brain

Link Between T. gondii Infection, Glioma Risk Examined

Significant increase in glioma risk seen for those with higher antibody titers to the sag-1 antigen

Dexamethasone May Hinder Immunotherapy for Glioblastoma

Findings seen in preclinical studies of mice, survival data from patients receiving PD-(L)1 blockade for GBM

Treatment disparities may explain worse outcomes for pediatric black and Hispanic brain cancer patients

Pediatric Brain Cancer Outcomes Worse for Black, Hispanic Patients

Disparities for disease severity not seen at diagnosis, meaning postdiagnosis factors may affect outcome
Maximal resection of a contrast-enhanced tumor is associated with improved overall survival in patients with isocitrate dehydrogenase gene 1 or 2 (IDH)-wild-type and IDH-mutant subtype glioblastomas

Maximal Resection of Glioblastomas May Up Survival

Maximal resection of contrast-enhanced tumor linked to increased overall survival across all subgroups
An application has been developed to predict clinical malignancy and survival outcomes for meningioma

Smartphone, Web App May Help Predict Prognosis for Meningioma

Models could predict meaningful individual-specific clinical outcome variables for survival, malignancy
A novel workflow that combines advanced optical imaging with an artificial intelligence algorithm may accurately diagnose brain tumors in real time in the operating room

Laser-Based Imaging + AI May Diagnose Brain Tumors in OR

Accurate diagnosis in <150 seconds in the operating room could improve decision-making during surgery
Use of a response- and biology-based treatment algorithm for intermediate-risk neuroblastoma is associated with excellent survival and reduces treatment for some patients

Algorithm Based on Response, Biology Guides Neuroblastoma Tx

Survival excellent with treatment algorithm for children with intermediate-risk neuroblastoma
The percentage of patients achieving five-year survival following a glioblastoma diagnosis remains both steady and low

Five-Year Overall Survival for Glioblastoma Persistently Low

Authors call for more aggressive treatments to be considered for glioblastoma patients